Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Antiviral Therapy on HBV Reactivation and Liver Function After Hepatectomy for HBV-DNA Negative HBV-related Hepatocellular Carcinoma

NCT02829359 is registered in ClinicalTrials.gov with Guangxi Medical University as lead sponsor.

NCT NCT02829359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02829359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Antiviral Therapy on HBV Reactivation and Liver Function After Hepatectomy for HBV-DNA Negative HBV-related Hepatocellular Carcinoma
Lead sponsor
Guangxi Medical University
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2012
Completion date
December 31, 2015
Enrollment
200 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer